Left ventricular ejection fraction for sudden death risk stratification and guiding implantable cardioverter-defibrillators implantation

Journal of Cardiovascular Pharmacology

Volumn 55, Issue 5, 2010, Pages 450-455

  Buxton, Alfred E ^a   Ellison, Kristin E ^a   Lorvidhaya, Peem ^a   Ziv, Ohad ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

Ejection fraction; Risk stratification; Sudden cardiac death

Indexed keywords

CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; CORONARY ARTERY DISEASE; DEFIBRILLATOR; HEART LEFT VENTRICLE EJECTION FRACTION; HEART REPOLARIZATION; HEART VENTRICLE TACHYCARDIA; HIGH RISK PATIENT; HUMAN; MORTALITY; PARASYMPATHETIC FUNCTION; PATIENT IDENTIFICATION; PRACTICE GUIDELINE; PRIMARY PREVENTION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK ASSESSMENT; SUDDEN DEATH; SYMPATHETIC FUNCTION; TREATMENT INDICATION;

DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; HEART FUNCTION TESTS; HUMANS; PRACTICE GUIDELINES AS TOPIC; RISK ASSESSMENT; VENTRICULAR FUNCTION, LEFT;

EID: 77953014203     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/FJC.0b013e3181d9f49c     Document Type: Review

References (42)

1. Zheng Z-J, Croft JB, Giles WH, et al. Sudden cardiac death in the United States, 1989 to 1998. Circulation. 2001;104:2158-2163.
2. Cobb LA, Fahrenbruch C, Olsufka M, et al. Changing incidence of out-of-hospital ventricular fibrillation, 1980-2000. JAMA. 2002;288:3008-3013.
3. Bunch T, White R, Friedman P, et al. Trends in treated ventricular fibrillation out-of-hospital cardiac arrest: a 17-year population-based study. Heart Rhythm. 2004;3:255-259.
4. Lloyd-Jones D, Adams R, Brown T, et al. Heart disease and stroke statistics-2010 update. Circulation. 2010; 121: e1-e170.
5. Epstein AE, DiMarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices). J Am Coll Cardiol. 2008;51:2085-2105.
6. Jessup M, Abraham W, Casey D, et al. 2009 focused update: ACCF/AHA guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2009;53:1343-1282.
7. Krumholz H, Anderson J, Bachelder B, et al. ACC/AHA 2008 performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures for ST-Elevation and Non-ST-Elevation Myocardial Infarction). J Am Coll Cardiol. 2008;52:2046-2099.
8. Kushner F, Hand M, Smith SJ, et al. 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) : a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2009;54:2205-2241.
9. Anderson J, Adams C, Antman E, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction). Circulation. 2007; 116: e148-e304.
10. Halkin A, Stone GW, Dixon S, et al. Impact and determinants of left ventricular function in patients undergoing primary percutaneous coronary intervention in acute myocardial infarction. Am J Cardiol. 2005;96:325-331.
11. Solomon SD, Glynn RJ, Greaves S, et al. Recovery of ventricular function after myocardial infarction in the reperfusion era: the healing and early afterload reducing therapy study. Ann Intern Med. 2001;134:451-458.
12. Exner DV, Kavanagh KM, Slawnych MP, et al. Noninvasive risk assessment early after a myocardial infarction: The REFINE Study. J Am Coll Cardiol. 2007;50:2275-2284.
13. Wichterle D, Camm AJ, Malik M. Turbulence slope after atrial premature complexes is an independent predictor of mortality in survivors of acute myocardial infarction. J Cardiovasc Electrophysiol. 2004;15:1350-1356.
14. Hohnloser SH, Kuck KH, Dorian P, et al. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med. 2004;351:2481-2488.
15. Steinbeck G, Andresen D, Seidl K, et al; IRIS Investigators. Defibrillator implantation early after myocardial infarction. N Engl J Med. 2009;361:1427-1436.
16. Wilber D, Zareba W, Hall W, et al. Time dependence of mortality risk and defibrillator benefit after myocardial infarction. Circulation. 2004;109:1082-1084.
17. Gorgels APM, Gijsbers C, de Vreede-Swagemakers J, et al. Out-ofhospital cardiac arrest-the relevance of heart failure. The Maastricht Circulatory Arrest Registry. Eur Heart J. 2003;24:1204-1209.
18. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225-237.
19. Kadish A, Dyer A, Daubert J, et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med. 2004;350:2151-2158.
20. Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med. 1996;335:1933-1940.
21. Moss AJ, Zareba W, Hall WJ, et al; the Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877-883.
22. Rouleau JL, Talajic M, Sussex B, et al. Myocardial infarction patients in the 1990s-their risk factors, stratification and survival in Canada: the Canadian Assessment of Myocardial Infarction Study. J Am Coll Cardiol. 1996;27:1119-1127.
23. Stecker EC, Vickers C, Waltz J, et al. Population-based analysis of sudden cardiac death with and without left ventricular systolic dysfunction. Twoyear findings from the Oregon Sudden Unexpected Death Study. J Am Coll Cardiol. 2006;47:1161-1166.
24. Ross AM, Coyne KS, Moreyra E, et al. Extended mortality benefit of early postinfarction reperfusion. Circulation. 1998;97:1549-1556.
25. Bailey JJ, Berson AS, Handelsman H, et al. Utility of current risk stratification tests for predicting major arrhythmic events after myocardial infarction. J Am Coll Cardiol. 2001;38:1902-1911.
26. Bauer A, Barthel P, Schneider R, et al. Improved stratification of autonomic regulation for risk prediction in post-infarction patients with preserved left ventricular function (ISAR-Risk). Eur Heart J. 2009;30:576-583.
27. Bauer A, Guzik P, Barthel P, et al. Reduced prognostic power of ventricular late potentials in post-infarction patients of the reperfusion era. Eur Heart J. 2005;26:755-761.
28. Huikuri HV, Raatikainen MJP, Moerch-Joergensen R, et al. Prediction of fatal or near-fatal cardiac arrhythmia events in patients with depressed left ventricular function after an acute myocardial infarction. Eur Heart J. 2009;30:689-698.
29. Huikuri HV, Tapanainen JM, Lindgren K, et al. Prediction of sudden cardiac death after myocardial infarction in the beta-blocking era. J Am Coll Cardiol. 2003;42:652-658.
30. Makikallio TH, Barthel P, Schneider R, et al. Prediction of sudden cardiac death after acute myocardial infarction: role of Holter monitoring in the modern treatment era. Eur Heart J. 2005;26:762-769.
31. Hohnloser S, Klingenheben T, Zabel M, et al. Prevalence, characteristics and prognostic value during long-term follow-up of nonsustained ventricular tachycardia after myocardial infarction in the thrombolytic era. J Am Coll Cardiol. 1999;33:1895-1902.
32. Bigger J, Fleiss J, Kleiger R, et al. The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. Circulation. 1984;69:250-258.
33. Mukharji J, Rude R, Poole K, et al. Risk factors for sudden death after acute myocardial infarction: two year follow-up. Am J Cardiol. 1984;54:31-36.
34. Richards DA, Byth K, Ross DL, et al. What is the best predictor of spontaneous ventricular tachycardia and sudden death after myocardial infarction? Circulation. 1991;83:756-763.
35. Copie X, Hnatkova K, Staunton A, et al. Predictive power of increased heart rate versus depressed left ventricular ejection fraction and heart rate variability for risk stratification after myocardial infarction: result of a two year follow-up study. J Am Coll Cardiol. 1996;27:270-276.
36. Farrell TG, Bashir Y, Cripps T, et al. Risk stratification for arrhythmic events in postinfarction patients based on heart rate variability, ambulatory electrocardiographic variables and the signal-averaged electrocardiogram. J Am Coll Cardiol. 1991;18:687-697.
37. Kuchar DL, Thorburn CW, Sammel NL. Prediction of serious arrhythmic events after myocardial infarction: signal-averaged electrocardiogram, Holter monitoring and radionuclide ventriculography. J Am Coll Cardiol. 1987;9:531-538.
38. La Rovere MT, Pinna GD, Hohnloser SH, et al; for the ATRAMI Investigators. Baroreflex sensitivity and heart rate variability in the identification of patients at risk for life-threatening arrhythmias: implications for clinical trials. Circulation. 2001;103:2072-2077.
39. Buxton AE, Lee KL, Fisher JD, et al; the Multicenter Unsustained Tachycardia Trial Investigators. A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med. 1999;341:1882-1890.
40. Connolly S, Gent M, Roberts R, et al; for the CIDS Investigators. Canadian Implantable Defibrillator Study (CIDS)-A randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation. 2000;101:1297-1302.
41. Kuck K-H, Cappato R, Siebels J, et al; the CASH Investigators. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest. The Cardiac Arrest Study Hamburg. Circulation. 2000;102:748-754.
42. The Antiarrhythmics versus Implantable Defibrillators Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med. 1997;337:1576-1583.